Filter posts

Rare Disease Drug Development Increases but Challenges Remain

In a recent study published by Tufts University, researchers found that rare disease drug development …

The DISARM Act Can Help Fix the Broken Antibiotics Market

In a recent piece for Bloomberg, reporter Robert Langreth paints a harrowing picture of the quickly …

BIO 2019 Innovation Zone Company Snapshot: Litron Laboratories

The next big medical breakthrough is on the horizon and all it takes is one …

BIO 2019 Innovation Zone Company Snapshot: HealthRhythms, Inc.

The next big medical breakthrough is on the horizon and all it takes is one …

BIO 2019 Innovation Zone Company Snapshot: Trellis Biosciences

The next big medical breakthrough is on the horizon and all it takes is one …

New BIO Report on State of Innovation for Alzheimer’s Disease Therapeutics

Today, BIO released a new report: The State of Innovation in Highly Prevalent Chronic Diseases …

GMOS are NOT "As Seen on Social Media"

It’s pretty safe to say that there’s a lot of misinformation on social media today, …

Nominate your company to be the Buzz of BIO at #BIO2018!

Are you an innovative biotech company that is R&D-intensive and looking to develop strategic partnerships …

ICYMI: Drug Development is Complicated. Let’s Start with the Facts.

Here’s a fact you might not have known: 90% of drug development programs fail. Yet …

ITIF Reports on Economic and Innovative Opportunities from Brain R&D

Biotechnology is healing the world and saving lives on a daily basis by curing and …